Literature DB >> 29175290

Trends and key correlates of prescription opioid injection misuse in the United States.

Christopher M Jones1.   

Abstract

BACKGROUND: Despite concerns over increasing harms associated with prescription opioid injection misuse, there is a paucity of research on the magnitude, characteristics, injection practices, and syringe sources for people who inject prescription opioids; limiting the implementation of targeted policy and programmatic initiatives.
MATERIALS AND METHODS: Data from the 2003 through 2014 National Surveys on Drug Use and Health were used to estimate prescription opioid injection trends and examine risky injection practices and syringe sources for people who inject prescription opioids. Multivariable logistic regression was used to identify characteristics associated with prescription opioid injection.
RESULTS: Among people 12years or older, the rate of prescription opioid injection misuse increased from 1.6 per 1000 in 2003-2005 to 2.7 per 1000 in 2012-2014 (p value for trend <0.05). Groups with increased odds of prescription opioid injection included: males, non-Hispanic whites, having an annual household income <$50,000, the uninsured, people with Medicaid, and people with past-year use disorders for cocaine, heroin, or prescription opioids. Risky injection practices such as reusing a needle and sharing needles were common among people with a history of prescription opioid injection misuse.
CONCLUSION: This study found significant increases in prescription opioid injection misuse trends in the U.S. These findings underscore the need to bring to scale evidence-based interventions to increase the provision of medication-assisted treatment for opioid use disorders and expand access to comprehensive risk-reduction services for people who inject drugs.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Opioid abuse; Opioid addiction; Prescription opioid injection

Mesh:

Substances:

Year:  2017        PMID: 29175290     DOI: 10.1016/j.addbeh.2017.10.018

Source DB:  PubMed          Journal:  Addict Behav        ISSN: 0306-4603            Impact factor:   3.913


  16 in total

1.  Frontline Science: Buprenorphine decreases CCL2-mediated migration of CD14+ CD16+ monocytes.

Authors:  Matias Jaureguiberry-Bravo; Lillie Lopez; Joan W Berman
Journal:  J Leukoc Biol       Date:  2018-05-23       Impact factor: 4.962

2.  Trends in Indicators of Injection Drug Use, Indian Health Service, 2010-2014 : A Study of Health Care Encounter Data.

Authors:  Mary E Evans; Marissa Person; Brigg Reilley; Jessica Leston; Richard Haverkate; Jeffrey T McCollum; Andria Apostolou; Michele K Bohm; Michelle Van Handel; Danae Bixler; Andrew J Mitsch; Dana L Haberling; Sarah M Hatcher; Thomas Weiser; Kim Elmore; Eyasu H Teshale; Paul J Weidle; Philip J Peters; Kate Buchacz
Journal:  Public Health Rep       Date:  2020-07-07       Impact factor: 2.792

3.  The Affordable Care Act and Opioid Agonist Therapy for Opioid Use Disorder.

Authors:  Ramin Mojtabai; Christine Mauro; Melanie M Wall; Colleen L Barry; Mark Olfson
Journal:  Psychiatr Serv       Date:  2019-04-30       Impact factor: 3.084

4.  Substance Use Stigma and Antiretroviral Therapy Adherence Among a Drug-Using Population Living with HIV.

Authors:  Kristi Lynn Stringer; Phillip Marotta; Elizabeth Baker; Bulent Turan; Mirjam-Colette Kempf; Patricia Drentea; Irena Stepanikova; Janet M Turan
Journal:  AIDS Patient Care STDS       Date:  2019-06       Impact factor: 5.078

5.  Medication Treatment For Opioid Use Disorders In Substance Use Treatment Facilities.

Authors:  Ramin Mojtabai; Christine Mauro; Melanie M Wall; Colleen L Barry; Mark Olfson
Journal:  Health Aff (Millwood)       Date:  2019-01       Impact factor: 6.301

Review 6.  The American Opioid Epidemic in Special Populations: Five Examples.

Authors:  Carlos Blanco; Mir M Ali; Aaron Beswick; Karen Drexler; Cheri Hoffman; Christopher M Jones; Tisha R A Wiley; Allan Coukell
Journal:  NAM Perspect       Date:  2020-10-26

7.  Analysis of genetic and clinical factors associated with buprenorphine response.

Authors:  Richard C Crist; Rachel Vickers-Smith; Rachel L Kember; Christopher T Rentsch; Heng Xu; E Jennifer Edelman; Emily E Hartwell; Kyle M Kampman; Henry R Kranzler
Journal:  Drug Alcohol Depend       Date:  2021-08-28       Impact factor: 4.852

8.  Use of Population-Based Surveys for Estimating the Population Size of Persons Who Inject Drugs in the United States.

Authors:  Heather Bradley; Elizabeth M Rosenthal; Meredith A Barranco; Tomoko Udo; Patrick S Sullivan; Eli S Rosenberg
Journal:  J Infect Dis       Date:  2020-09-02       Impact factor: 5.226

9.  Estimated effect of US state syringe sale policy on source of last-used injection equipment.

Authors:  Patrick Janulis; Barrett W Montgomery; James C Anthony
Journal:  Int J Drug Policy       Date:  2019-12-13

10.  Epidemiology of the U.S. opioid crisis: the importance of the vector.

Authors:  Wilson M Compton; Christopher M Jones
Journal:  Ann N Y Acad Sci       Date:  2019-08-04       Impact factor: 6.499

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.